TransMedics Group reported earnings of $ 0.51 per TMDX share on Nov 5, 2026, beating analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | $ 0.2976 |
| Earnings Per Share (Surprise) | $ 0.51 (+$ 0.2124) |
| Last Year's EPS | $ 0.7125 |
| EPS YoY Change |
Out of the last 39 earnings reporting periods, TransMedics Group beat analysts’ expectations 16 times and fell short of expectations 15 time(s). TransMedics Group reported earnings per share of $ 0.51 in the last report surpassing an estimated EPS of $ 0.2976 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | $ 0.2976 | $ 0.51 | $ 0.66 | |
| Aug 4, 2026 | $ 0.4955 | $ 0.44 | $ 0.92 | |
| May 5, 2026 | $ 0.62 | $ 0.30 | $ 0.70 | |
| Feb 24, 2026 | $ 0.41 | $ 0.57 | $ 0.19 | |
| Oct 29, 2025 | $ 0.37 | $ 0.66 | $ 0.12 | |
| Jul 30, 2025 | $ 0.48 | $ 0.92 | $ 0.35 | |
| May 8, 2025 | $ 0.29 | $ 0.70 | $ 0.35 | |
| Feb 27, 2025 | $ 0.22 | $ 0.19 | $ 0.12 | |
| Oct 28, 2024 | $ 0.29 | $ 0.12 | -$ 0.78 | |
| Jul 31, 2024 | $ 0.21 | $ 0.35 | -$ 0.03 | |
| Apr 30, 2024 | $ 0.03256 | $ 0.35 | -$ 0.08 | |
| Feb 26, 2024 | $ 0.02 | $ 0.12 | -$ 0.21 | |
| Nov 6, 2023 | -$ 0.18 | -$ 0.78 | -$ 0.25 | |
| Aug 3, 2023 | -$ 0.15 | -$ 0.03 | -$ 0.41 | |
| May 1, 2023 | -$ 0.25 | -$ 0.08 | -$ 0.38 | |
| Feb 22, 2023 | -$ 0.28 | -$ 0.21 | -$ 0.46 | |
| Nov 3, 2022 | -$ 0.40 | -$ 0.25 | -$ 0.47 | |
| Aug 1, 2022 | -$ 0.32 | -$ 0.41 | -$ 0.39 | |
| May 3, 2022 | -$ 0.35 | -$ 0.38 | -$ 0.29 | |
| Feb 23, 2022 | -$ 0.43 | -$ 0.46 | -$ 0.23 |
TransMedics Group’s stock was trading at $ 72.76 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, TMDX’s price increased to $ 88.24 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | $ 0.51 | $ 72.76 | $ 88.24 | |
| Aug 4, 2026 | $ 0.44 | $ 81.55 | $ 76.49 | |
| May 5, 2026 | $ 0.30 | $ 97.08 | $ 72.92 | |
| Feb 24, 2026 | $ 0.57 | $ 134.65 | $ 131.85 | |
| Oct 29, 2025 | $ 0.66 | $ 129.71 | $ 135.79 | |
| Jul 30, 2025 | $ 0.92 | $ 104.83 | $ 118.97 | |
| May 8, 2025 | $ 0.70 | $ 95.81 | $ 111.50 | |
| Feb 27, 2025 | $ 0.19 | $ 73.76 | $ 76.32 | |
| Oct 28, 2024 | $ 0.12 | $ 125.17 | $ 88.50 | |
| Jul 31, 2024 | $ 0.35 | $ 138.43 | $ 151.51 | |
| Apr 30, 2024 | $ 0.35 | $ 97.25 | $ 117.60 | |
| Feb 26, 2024 | $ 0.12 | $ 83.14 | $ 88.71 | |
| Nov 6, 2023 | -$ 0.78 | $ 42.62 | $ 60.76 | |
| Aug 3, 2023 | -$ 0.03 | $ 88.06 | $ 80.26 | |
| May 1, 2023 | -$ 0.08 | $ 79.10 | $ 73.82 | |
| Feb 22, 2023 | -$ 0.21 | $ 64.74 | $ 77.80 | |
| Nov 3, 2022 | -$ 0.25 | $ 46.36 | $ 55.96 | |
| Aug 1, 2022 | -$ 0.41 | $ 40.38 | $ 37.28 | |
| May 3, 2022 | -$ 0.38 | $ 22.00 | $ 30.69 | |
| Feb 23, 2022 | -$ 0.46 | $ 13.28 | $ 16.36 |
TransMedics Group released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
TransMedics Group beat analysts’ expectations during the last earnings period by
